These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15520058)

  • 21. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer.
    Kim JA; Lee J; Han B; Park SH; Park JO; Park YS; Lim HY; Kang WK
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):177-84. PubMed ID: 20878159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CPT-11 combined chemotherapy for metastatic gastric cancer].
    Narahara H; Sugimoto N; Iishi H; Tatsuta M
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1973-7. PubMed ID: 15570923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Capecitabine for the treatment of gastric cancer.
    Kim TY; Oh DY; Bang YJ
    Expert Rev Gastroenterol Hepatol; 2015; 9(12):1471-81. PubMed ID: 26470733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).
    Leong T; Smithers BM; Michael M; Gebski V; Boussioutas A; Miller D; Simes J; Zalcberg J; Haustermans K; Lordick F; Schuhmacher C; Swallow C; Darling G; Wong R
    BMC Cancer; 2015 Jul; 15():532. PubMed ID: 26194186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy of advanced gastric cancer.
    Rivera F; Vega-Villegas ME; López-Brea MF
    Cancer Treat Rev; 2007 Jun; 33(4):315-24. PubMed ID: 17376598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Latest progress on chemotherapy for advanced gastric cancer].
    Tahara M; Ohtsu A
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2048-58. PubMed ID: 11103236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) study.
    Guimbaud R; Louvet C; Ries P; Ychou M; Maillard E; André T; Gornet JM; Aparicio T; Nguyen S; Azzedine A; Etienne PL; Boucher E; Rebischung C; Hammel P; Rougier P; Bedenne L; Bouché O
    J Clin Oncol; 2014 Nov; 32(31):3520-6. PubMed ID: 25287828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis.
    Ter Veer E; Haj Mohammad N; van Valkenhoef G; Ngai LL; Mali RMA; Anderegg MC; van Oijen MGH; van Laarhoven HWM
    J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27576566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
    Di Bartolomeo M; Buzzoni R; Mariani L; Ferrario E; Katia D; Gevorgyan A; Zilembo N; Bordonaro R; Bochicchio AM; Massidda B; Ardizzoia A; Marini G; Aitini E; Schieppati G; Comella G; Pinotti G; Palazzo S; Cicero G; Bajetta E; ; Villa E; Fagnani D; Reguzzoni G; Agostana B; Oliani C; Kildani B; Duro M; Botta M; Mozzana R; Mantovani G
    Oncology; 2006; 71(5-6):341-6. PubMed ID: 17855795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docetaxel in the treatment of gastric cancer.
    Thuss-Patience PC; Kretzschmar A; Reichardt P
    Future Oncol; 2006 Oct; 2(5):603-20. PubMed ID: 17026452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy for advanced gastric cancer.
    Wagner AD; Grothe W; Behl S; Kleber G; Grothey A; Haerting J; Fleig WE
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004064. PubMed ID: 15846694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of the toxicities and efficacies of the combination chemotherapy regimens in advanced gastric cancer patients who achieved complete response after chemotherapy].
    Kim YJ; Goh PG; Kim ES; Lee SY; Moon HS; Lee ES; Sung JK; Kim SH; Lee BS; Jeong HY
    Korean J Gastroenterol; 2011 Dec; 58(6):311-7. PubMed ID: 22198228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapeutic options for gastroesophageal junction tumors.
    Ku GY; Ilson DH
    Semin Radiat Oncol; 2013 Jan; 23(1):24-30. PubMed ID: 23207044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer.
    Kucukzeybek Y; Dirican A; Erten C; Somali I; Can A; Demir L; Bayoglu IV; Akyol M; Medeni M; Tarhan MO
    Asian Pac J Cancer Prev; 2012; 13(6):2771-4. PubMed ID: 22938457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies.
    Barone C; Corsi DC; Pozzo C; Cassano A; Fontana T; Noviello MR; Landriscina M; Colloca G; Astone A
    Cancer; 1998 Apr; 82(8):1460-7. PubMed ID: 9554521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy options for gastric cancer.
    Meyerhardt JA; Fuchs CS
    Semin Radiat Oncol; 2002 Apr; 12(2):176-86. PubMed ID: 11979419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.
    Boku N; Yamamoto S; Fukuda H; Shirao K; Doi T; Sawaki A; Koizumi W; Saito H; Yamaguchi K; Takiuchi H; Nasu J; Ohtsu A;
    Lancet Oncol; 2009 Nov; 10(11):1063-9. PubMed ID: 19818685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan.
    Kang BW; Kim JG; Kwon OK; Chung HY; Yu W
    World J Gastroenterol; 2014 May; 20(18):5396-402. PubMed ID: 24833869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study.
    Thuss-Patience PC; Kretzschmar A; Repp M; Kingreen D; Hennesser D; Micheel S; Pink D; Scholz C; Dörken B; Reichardt P
    J Clin Oncol; 2005 Jan; 23(3):494-501. PubMed ID: 15659494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.